Related Experiment Video
Updated: Aug 5, 2026

Engineering and Evolution of Synthetic Adeno-Associated Virus (AAV) Gene Therapy Vectors via DNA Family Shuffling
Published on: April 2, 2012
Human cDNA clones that modify radiomimetic sensitivity of ataxia-telangiectasia (group A) cells
Y Ziv1, A Bar-Shira, T J Jorgensen
1Department of Human Genetics, Sackler School of Medicine, Tel Aviv University, Ramat Aviv, Israel.
Abstract:
Genes responsible for genetic diseases with increased sensitivity to DNA-damaging agents can be identified using complementation cloning. This strategy is based on in vitro complementation of the cellular sensitivity by gene transfer. Ataxia-telangiectasia (A-T) is a multisystem autosomal recessive disorder involving cellular sensitivity to ionizing radiation and radiomimetic drugs. A-T is genetically heterogeneous, with four complementation groups. We attempted to identify cDNA clones that modify the radiomimetic sensitivity of A-T cells assigned to complementation group [A-T(A)]. The cells were transfected with human cDNA libraries cloned in episomal vectors, and various protocols of radiomimetic selection were applied. Thirteen cDNAs rescued from survivor cells were found to confer various degrees of radiomimetic resistance to A-T(A) cells upon repeated introduction, and one of them also partially influenced another feature of the A-T phenotype, radioresistant DNA synthesis. None of the clones mapped to the A-T locus on chromosome 11q22-23. Nine of the clones were derived from known genes, some of which are involved in cellular stress responses. We concluded that a number of different genes, not necessarily associated with A-T, can influence the response of A-T cells to radiomimetic drugs, and hence the complementation cloning approach may be less applicable to A-T than to other diseases involving abnormal processing of DNA damage.
Insights
Complementation cloning identified thirteen cDNAs that altered radiomimetic drug sensitivity in Ataxia-telangiectasia (A-T) cells. This suggests multiple genes, not solely A-T related, influence cellular responses to DNA damage.
Area of Science:
- Genetics
- Molecular Biology
- Cell Biology
Background:
- Ataxia-telangiectasia (A-T) is a genetic disorder characterized by sensitivity to DNA-damaging agents.
- Genetic heterogeneity exists in A-T, with at least four complementation groups identified.
- Complementation cloning is a strategy to identify genes responsible for cellular sensitivity to DNA damage.
Purpose of the Study:
- To identify complementary DNA (cDNA) clones that modify the sensitivity of A-T cells (complementation group A) to radiomimetic drugs.
- To investigate the applicability of complementation cloning for identifying genes involved in A-T.
Main Methods:
- Transfection of A-T cells with human cDNA libraries cloned in episomal vectors.
- Application of various radiomimetic drug selection protocols to isolate resistant cells.
- Analysis of rescued cDNAs for their ability to confer resistance and influence A-T phenotypes.
Main Results:
- Thirteen cDNAs were identified that conferred varying degrees of radiomimetic resistance to A-T(A) cells.
- One cDNA clone also partially affected radioresistant DNA synthesis, another A-T phenotype.
- None of the identified cDNAs mapped to the known A-T locus on chromosome 11q22-23.
- Nine cDNAs were derived from known genes, some involved in cellular stress responses.
Conclusions:
- Multiple genes, not necessarily directly linked to Ataxia-telangiectasia, can influence the response of A-T cells to radiomimetic drugs.
- The complementation cloning approach may have limitations in identifying A-T-specific genes due to the involvement of numerous cellular pathways.
- Further research is needed to fully understand the genetic basis of A-T and its complex cellular responses to DNA damage.
More Related Videos
09:13Generation of Cancer Cell Clones to Visualize Telomeric Repeat-containing RNA TERRA Expressed from a Single Telomere in Living Cells
Published on: January 17, 2019
12:04Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells
Published on: March 10, 2023
Related Concept Videos
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle